Cargando…

Serum Sclerostin, Body Composition, and Sarcopenia in Hemodialysis Patients with Diabetes

Sclerostin (Scl) is an osteoblast-inhibiting glycoprotein that is secreted mainly by osteocytes and is regulated by hormonal changes and skeletal loading. Decreased physical function and high serum Scl concentrations have been reported in chronic renal failure patients but little is known to date ab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Medeiros, Maria Carolina, Rocha, Natalia, Bandeira, Elba, Dantas, Isabel, Chaves, Conceição, Oliveira, Mario, Bandeira, Francisco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035555/ https://www.ncbi.nlm.nih.gov/pubmed/32095286 http://dx.doi.org/10.1155/2020/4596920

Ejemplares similares

Serum Sclerostin Is Associated With Central Fat Distribution in Patients With Type 2 Diabetes and Peripheral Neuropathy
por: Costi, Bruna, et al.
Publicado: (2021)

Decreased Serum Level of Sclerostin in Older Adults with Sarcopenia
por: Ahn, Seong Hee, et al.
Publicado: (2022)

Serum sclerostin is an independent predictor of mortality in hemodialysis patients
por: Gonçalves, Flávia Letícia Carvalho, et al.
Publicado: (2014)

Sclerostin as a Putative Myokine in Sarcopenia
por: Yi, Hyon-Seung
Publicado: (2022)

Serum Sclerostin Level Is Negatively Associated with Bone Mineral Density in Hemodialysis Patients
por: Lu, Jing-Wun, et al.
Publicado: (2022)

Sclerostin in Excessive Drinkers: Relationships with Liver Function and Body Composition
por: Martín González, Candelaria, et al.
Publicado: (2022)

What is the relationship between sclerostin and cardiovascular events in hemodialysis patients?
por: Zhao, Yu, et al.
Publicado: (2020)

Sarcopenia and Mortality in Older Hemodialysis Patients
por: Sánchez-Tocino, M. Luz, et al.
Publicado: (2022)

Serum sclerostin levels in osteoporotic fracture patients
por: Gorter, Erwin A., et al.
Publicado: (2022)

Sclerostin
por: Silverman, Stuart L.
Publicado: (2010)

Treatment with cinacalcet increases plasma sclerostin concentration in hemodialysis patients with secondary hyperparathyroidism
por: Kuczera, Piotr, et al.
Publicado: (2016)

Evaluation of Small Fiber Peripheral Neuropathy With Infrared Thermographic Camera in Prediabetes
por: Vasconcellos, Larissa Frazao, et al.
Publicado: (2021)

Serum Sclerostin in Hepatitis C Virus Infected Patients
por: González-Reimers, Emilio, et al.
Publicado: (2014)

The effect of single extremity-vibration on the serum sclerostin level
por: Cakar, Halil Ibrahim, et al.
Publicado: (2015)

FGF-23 and sclerostin in serum and bone of CKD patients
por: Lima, Florence, et al.
Publicado: (2023)

FRI113 Increased Body Fat Is Associated With Heart Failure Of Ischemic Cause
por: Bandeira, Francisco, et al.
Publicado: (2023)

Sarcopenia: Body Composition and Gait Analysis
por: Fan, Yuxuan, et al.
Publicado: (2022)

Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
por: van Dinther, Maarten, et al.
Publicado: (2013)

Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study
por: Brandenburg, Vincent M, et al.
Publicado: (2013)

Experience With Anti-Sclerostin Antibody for Osteoporosis Patient With End-Stage Renal Disease on Hemodialysis
por: Mukaddam, Mona Al, et al.
Publicado: (2021)

Low Bone Mass is Associated with Increased Carotid Intima Media Thickness in Men with Type 2 Diabetes Mellitus
por: de Almeida Pereira Coutinho, Mario, et al.
Publicado: (2013)

Body Composition in Acromegaly According to Disease Activity – Performance of Dual X-Ray Absorptiometry and Multifrequency Bioelectrical Impedance Analysis
por: Lopes, Aline Alves, et al.
Publicado: (2022)

Serum sclerostin in vascular calcification in CKD: a meta-analysis
por: Lin, Yan, et al.
Publicado: (2023)

Urinary Calcium Is Associated with Serum Sclerostin among Stone Formers
por: Rodrigues, Fernanda Guedes, et al.
Publicado: (2023)

Controversies in the treatment of postmenopausal osteoporosis: How long to treat with bisphosphonates?
por: Bandeira, Francisco, et al.
Publicado: (2020)

The role of obesity in sarcopenia and the optimal body composition to prevent against sarcopenia and obesity
por: Liu, Chaoran, et al.
Publicado: (2023)

Physical Activity, Body Composition, Serum Myokines and the Risk of Death in Hemodialysis Patients
por: Koźma-Śmiechowicz, Martyna A., et al.
Publicado: (2023)

Sclerostin and Vascular Pathophysiology
por: Catalano, Antonino, et al.
Publicado: (2020)

Sclerostin and Cardiovascular Disease
por: Tobias, Jonathan H.
Publicado: (2023)

Associations of sclerostin with carotid artery atherosclerosis and all-cause mortality in Chinese patients undergoing maintenance hemodialysis
por: Chen, Aiqun, et al.
Publicado: (2018)

Physical Activity versus Sclerostin and Interleukin 6 Concentration in Patients Receiving Renal Replacement Therapy by Hemodialysis
por: Turoń-Skrzypińska, Agnieszka, et al.
Publicado: (2020)

Successful treatment of thyrotoxicosis is accompanied by a decrease in serum sclerostin levels
por: Skowrońska-Jóźwiak, Elżbieta, et al.
Publicado: (2012)

Serum sclerostin in high-activity adult patients with juvenile idiopathic arthritis
por: Brabnikova-Maresova, Kristyna, et al.
Publicado: (2014)

Serum sclerostin levels in renal cell carcinoma patients with bone metastases
por: Wibmer, C., et al.
Publicado: (2016)

Serum sclerostin is negatively associated with insulin sensitivity in obese but not lean women
por: Aznou, Anouar, et al.
Publicado: (2021)

Acute Response of Sclerostin to Whole-body Vibration with Blood Flow Restriction
por: Gapper, Kyle S, et al.
Publicado: (2021)

Recent Issues on Body Composition Imaging for Sarcopenia Evaluation
por: Lee, Koeun, et al.
Publicado: (2019)

Association of Body Composition and Sarcopenia with NASH in Obese Patients
por: Schmitz, Sophia Marie-Therese, et al.
Publicado: (2021)

Characterization of the gut microbiota in hemodialysis patients with sarcopenia
por: Zhou, Qifan, et al.
Publicado: (2021)

Sarcopenia and osteosarcopenia among patients undergoing hemodialysis
por: Xiang, Ting, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tfkplrupf8sjoh8obba6h7m6q0